892 Results for Multiple Sclerosis

  1. At the Bench-Multiple Sclerosis: Unraveling the Role of Cholesterol in MS Pathogenesis

    ...ARTICLE IN BRIEFTwo different animal studies uncovered insights into cholesterol's role in MSone, by looking at its role in limiting remyelination in the aged central nervous system, and the other by looking at how

    • Talan, Jamie
    • Neurology Today
    • February 22, 2018
  2. In the Clinic – Multiple Sclerosis: Longer Duration of Breastfeeding Associated with Reduced MS Risk

    ...ARTICLE IN BRIEFA new analysis suggests that among women who gave birth, a longer duration of breastfeeding (at least 15 months) is associated with a reduced risk of developing MS or CIS. But further studies are needed

    • Owens, Sarah
    • Neurology Today
    • September 07, 2017
  3. In the Clinic-Multiple Sclerosis: The Benefits of a Balance Training Program for MS

    ...ARTICLE IN BRIEFParticipants in a training program for people with multiple sclerosis (MS) that incorporates balance and eye-movement exercises showed greater balance improvements than other MS patients who did

    • Collins, Thomas R.
    • Neurology Today
    • March 22, 2018
  4. In the Clinic-MS: Updated McDonald Criteria Aim to Improve MS Diagnosis

    ...ARTICLE IN BRIEFA panel of MS experts has updated the McDonald criteria with five revisions.The McDonald criteria, a set of evolving diagnostic criteria for multiple sclerosis (MS) that combines clinical, imaging

    • Rukovets, Olga
    • Neurology Today
    • February 08, 2018
  5. In the Clinic-Multiple Sclerosis: Siponimod Slows Disability Progression in Secondary Progressive MS, Modestly

    ...ARTICLE IN BRIEFIn a phase 3 trial, siponimod significantly slowed progression of secondary progressive multiple sclerosis, but commentators noted the effect was modest.Figure. DR. ROBERT J. FOX: “Progressive MS

    • Robinson, Richard
    • Neurology Today
    • April 19, 2018
  6. In the Clinic-Multiple Sclerosis: Randomized Clinical Trial Finds Venous Angioplasty Ineffective for MS

    ...ARTICLE IN BRIEFA randomized, phase 3 trial found that venous percutaneous transluminal angioplasty is largely ineffective and should not be used treat MS patients.The theory has been the subject of controversy ever

    • Kreimer, Susan
    • Neurology Today
    • January 11, 2018